🇺🇸 FDA
Pipeline program

Placebo matching AMX0035, AMX0035

A35-009

Phase 3 small_molecule active

Quick answer

Placebo matching AMX0035, AMX0035 for Progressive Supranuclear Palsy is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Progressive Supranuclear Palsy
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials